Sorrento Therapeutics Inc (SRNEQ) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sorrento Therapeutics Inc   (SRNEQ)


Sorrento Therapeutics Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sorrento Therapeutics Inc's ROI in the second quarter of 2023?
Sorrento Therapeutics Inc recorded a cumulative net loss of $-354 million during 12 months ending in the second quarter of 2023, resulting in a negative return on investment (ROI) of -135.39%.

Within the Healthcare sector Sorrento Therapeutics Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2023 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM -54.03 % -43.85 % -24.55 % 0.05 % 14.86 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 199 293 142 412 491
Return On Investment (TTM) -135.39 % -139.05 % -82.72 % -94.01 % -92.33 %
SRNEQ's Overall Ranking # # # # #
Seq. Investment Change TTM -21.82 % -21.15 % -19.58 % -7.28 % -4.51 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -354 -465 -351 -496 -525

SRNEQ Company Profile >> Back to SRNEQ Roi Comparisons >> See Annual SRNEQ Return On Investment



Return On Investment SRNEQ's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Sorrento Therapeutics Inc's II. Quarter Investments $ 199 Millions SRNEQ's Balance sheet
Sorrento Therapeutics Inc's II. Quarter Income $ -109 Millions Quarterly SRNEQ's Income Statement
SRNEQ's Income by Division See SRNEQ's Income by Division


SRNEQ Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 142 555 415 397 560
Y / Y Investment Growth -74.43 % 33.7 % 4.62 % -29.24 % 55.82 %
Net Income in Millions -578 -429 -314 -363 -213
Y / Y Net Income Growth - - - - -
Annual Return On Investment -407.29 % -77.36 % -75.78 % -91.53 % -37.92 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SRNEQ's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SRNEQ's Competitors
Subscribers only: Roi for Sorrento Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for SRNEQ's Customers

Other Ratios
SRNEQ's Roa SRNEQ's Inventory Turnover Ratio SRNEQ's Growth Rates SRNEQ's Dividend Statistics
SRNEQ's Profitability Ratios SRNEQ's Asset Turnover Ratio SRNEQ's Dividend Growth
SRNEQ's Roe SRNEQ's Valuation Ratios SRNEQ's Financial Strength Ratios SRNEQ's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.